World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03078712
Date of registration: 06/03/2017
Prospective Registration: No
Primary sponsor: Pontificia Universidad Catolica de Chile
Public title: Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study ANDROMEDA
Scientific title: Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study
Date of first enrolment: March 1, 2017
Target sample size: 424
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03078712
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Chile
Contacts
Name:     Glenn Hernandez, PhD
Address: 
Telephone:
Email:
Affiliation:  Pontificia Universidad Catolica de Chile
Key inclusion & exclusion criteria

Inclusion Criteria:

- Septic shock diagnosed at ICU admission according to the Sepsis-3 Consensus
Conference, (basically septic patients with hypotension requiring norepinephrine (NE)
to maintain a mean arterial pressure (MAP) of = 65 mmHg, and serum lactate levels > 2
mmol/l after initial fluid resuscitation with at least 20/ml kg in one hour.

Exclusion Criteria:

- Pregnancy

- Anticipated surgery or dialysis procedure during the first 8h after septic shock
diagnosis

- Do-not-resuscitate status

- Child B or C liver cirrhosis

- Active bleeding

- Acute hematological malignancy

- Severe concomitant acute respiratory distress syndrome (ARDS)

- More than 4h after officially meeting septic shock criteria



Age minimum: 18 Years
Age maximum: 90 Years
Gender: All
Health Condition(s) or Problem(s) studied
Hyperlactatemia
Peripheral Perfusion
Septic Shock
Intervention(s)
Other: Lactate guided resuscitation
Other: Peripheral Perfusion guided resuscitation
Primary Outcome(s)
All-cause of mortality [Time Frame: 28 days]
Secondary Outcome(s)
Need of mechanical ventilation [Time Frame: 28 days]
Variations in Sequential Organ failure Assessment (SOFA) [Time Frame: At 8, 24, 48 and 72 hours]
Need of renal replacement therapies (RRT) [Time Frame: 28 days]
Days free of MV, vasopressors and RRT [Time Frame: 28 days]
Secondary ID(s)
161130002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history